Abstract:
The invention discloses superparamagnetic monodispersed particles, their method of preparation and their uses. These particles comprise: a core of a first polymer, an internal layer of a second polymer coating the core, and in which is distributed a magnetic material, and an external layer of a third polymer coating the magnetic layer, and capable of interacting with at least one biological molecule, at least the second polymer being heat sensitive and having a predetermined lower critical solubility temperature (LCST) of 15 to 65 DEG C.
Abstract:
Novel N-RES agents for use in vitro and in vivo medical and biological applications, such as, for example MRI and/or intravenous administration of pharmaceutical agents are described. The novel N-RES agents are prepared by coating inorganic core particles with a poly(acrylic acid) - poly(alkylene ether) graft copolymer. The resulting polymer-coated inorganic particle cores are useful as imaging agents, therapeutic agents or carriers having increased circulation time due to decrease uptake or recognition by the RES.
Abstract:
Magnetically responsive particles and to their use in systems in which the separation of certain molecules from the surrounding medium is necessary or desirable are disclosed. The magnetically responsive particles consist of a metal, metal oxide or metal alloy core, coated with an organo-metallic polymer having attached thereto an organic functionality to which a variety of organic and/or biological molecules can be coupled. The particles can be dispersed in aqueous media without rapid gravitational settling and conveniently reclaimed from the media using a magnetic field. The magnetically responsive particles of the invention may be coupled to biological or organic molecules with affinity for, or the ability to absorb, or which interact with certain other biological or organic molecules. Particles so coupled may be used in a variety of in vitro or in vivo systems involving separations steps or the directed movement of coupled molecules to particular sites, including immunological assays, other biological assays, biochemical or enzymatic reactions, affinity chromatographic purification, cell sorting and diagnostic and therapeutic uses.
Abstract:
The invention provides methodology for the direct coating of transiently stable, colloidal particulate magnetic substrates with various synthetic or naturally occurring polymers, particularly biologically active peptides and proteins.
Abstract:
This invention provides a novel process of producing magnetically responsive polymer particles comprising polymeric core particles coated evenly with a layer of polymer containing magnetically responsive metal oxide. A wide variety of polymeric particles with sizes ranging from 1 to 100 microns can be used as core particles and transformed into magnetically responsive polymer particles. The surface of these magnetically responsive polymer particles can be coated further with another layer of functionalized polymer. These magnetically responsive polymer particles can be used for passive or covalent coupling of biological material such as antigens, antibodies, enzymes or DNA/RNA hybridization and used as solid phase for various types of immunoassays, DNA/RNA hybridization probes assays, affinity purification, cell separation and other medical, diagnostic, and industrial applications.
Abstract:
The present invention relates to a method for obtaining intracellular molecules having specific affinity for a polyelectrolyte particle comprising a functionalized magnetic nanoparticle by transferring said polyelectrolyte particle into a eukaryotic cell comprising the intracellular molecule, wherein a conjugate is formed between the polyelectrolyte particle and the intracellular molecule. By recovering the conjugate from the eukaryotic cell and isolating the intracellular molecule from the conjugate, the intracellular molecule can be obtained and subsequently analyzed. The present invention further relates to the use of such a polyelectrolyte particle for identifying and/or isolating a subset of eukaryotic cells comprising the polyelectrolyte particle from a plurality of eukaryotic cells, and for isolating a complex formed between the polyelectrolyte particle and a polyanion from polyelectrolyte particles not in complex with the polyanion. Furthermore, the present invention relates to the use of an intracellular molecule for modifying the expression of a nucleic acid transfected into a eukaryotic cell by means of such a polyelectrolyte particle.
Abstract:
Magnetic particles which comprise a particulate magnetic material and, formed on the surface thereof, an readily decomposable or readily soluble polymer coating layer containing a reactive component; and a method for producing a reaction product using the magnetic particles. The use of the above magnetic particles allows the combination of the efficient progress of a solid state reaction and the easiness of the recovery of reaction product.
Abstract:
A method for preparing nanoparticles coated with magnetic metal oxide, comprising the following steps: a) contacting an aqueous solution containing a soluble polymeric metal chelating agent with one or more soluble metal salts providing metal ions, wherein at least one of said metal ions is capable of forming an oxide which is magnetic, said metal ions being in amounts which do not exceeed substantially the binding capacity of said chelating agent; b) causing said metal ions to be present in the oxidation states required for the formation of the oxide which is magnetic; c) maintaining the pH of the solution at the range of at least 7; d) introducing into the solution additional amounts of said metal salts; e) causing said additional metal ions to be present in the oxidation states required for the formation of the oxide which is magnetic; f) maintaining the pH of the solution at the range of at least 7; g) successively repeating the operations of steps d) to f) as many times as required to obtain monodispersed nanoparticles coated with magnetic metal oxide.
Abstract:
New superparamagnetic particles useful in medicine for destroying tumors, increasing immunity and diagnosing conditions are disclosed. For that purpose, very small superparamagnetic single-domain particles are aggregated and protected against further aggregation by chemical bonding of reactive stabilizer substances on the surface of the superparamagnetic particles. These new particles thus consist of stable, decomposable aggregates with a particle size in a range between 10 and 1000 nanometres and a defined behaviour in a magnetic field. The aggregates consist of several small superparamagnetic single-domain particles of iron oxide, iron mixed oxide or iron, with a particle size in a range between 3 and 20 nanometres, bearing on their surface chemically bound organic substances from the group comprising the phosphate, diphosphate, polyphosphate, thiophosphate, phosphonate or group containing polyalkylene glycols, phosphate group containing nucleotides, their oligomers or polymers, as well as phosphate group containing carbohydrates, which may present further binding sites. Both the new disclosed superparamagnetic aggregates and reactive stabilizer substances may be active substances.